Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bonifen
2. Dipyridoxolyldisulfide
3. Encephabol
4. Enerbol
5. Hydrochloride, Pyritinol
6. Piriditol
7. Piritinol
8. Piritoxina
9. Pyridoxinedisulfide
10. Pyrithioxin
11. Pyrithioxine
12. Pyritinol Hydrochloride
1. Pyrithioxin
2. 1098-97-1
3. Pyrithioxine
4. Bonifen
5. Encefabol
6. Pyridoxine Disulfide
7. Piritinol
8. Bonol
9. Epocan
10. Vitamin B6 Disulfide
11. Dipyridoxolyldisulfide
12. Biocefalin
13. Pyridoxine-5-disulfide
14. Pyrithioxine [jan]
15. Ak5q5fzh2r
16. Nsc-759229
17. 5,5'-(disulfanediylbis(methylene))bis(4-(hydroxymethyl)-2-methylpyridin-3-ol)
18. Pyrithioxine Hydrochloride
19. 5-[[[5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methyldisulfanyl]methyl]-4-(hydroxymethyl)-2-methylpyridin-3-ol
20. Pyritinol (inn)
21. 4-pyridinemethanol, 3,3'-[dithiobis(methylene)]bis[5-hydroxy-6-methyl-
22. Pyrithioxine (jan)
23. Pyritioxine
24. Pyritinol [inn]
25. Piritinolo [dcit]
26. Piritinolo
27. Pyritinolum
28. Piritinol [inn-spanish]
29. Pyritinolum [inn-latin]
30. 4-pyridinemethanol, 3,3'-(dithiobis(methylene))bis(5-hydroxy-6-methyl-
31. 5,5'-[dithiobis(methylene)]bis[4-(hydroxymethyl)-2-methylpyridin-3-ol]
32. Pyritinol [inn:ban:dcf]
33. Ncgc00166140-01
34. Einecs 214-150-1
35. Unii-ak5q5fzh2r
36. 5,5'-(disulfanediyldimethanediyl)bis[4-(hydroxymethyl)-2-methylpyridin-3-ol]
37. Pyritinol [mi]
38. Pyritinol, Pyrithioxin
39. 3,3'-(dithiobis(methylene))bis(5-hydroxy-6-methyl-4-pyridinemethanol)
40. 4-pyridinemethanol, 3,3'-(dithiodimethylene)bis(5-hydroxy-6-methyl-
41. Pyritinol [who-dd]
42. Mls004712044
43. Schembl150551
44. Chembl488093
45. Pyrithioxin, Analytical Standard
46. Dtxsid3048362
47. Chebi:135554
48. Hms3264m15
49. Hms3886m13
50. Pharmakon1600-01505762
51. Hy-b0910
52. 3,3'-(dithiodimethylene)bis(5-hydroxy-6-methyl-4-pyridinemethanol)
53. Bbl028281
54. Mfcd00151477
55. Nsc759229
56. S5141
57. Stk801801
58. Zinc37866091
59. 5,5'-disulfanediylbis(methylene)bis(4-(hydroxymethyl)-2-methylpyridin-3-ol)
60. Akos005066380
61. Ccg-213980
62. Db13084
63. Nsc 759229
64. 5-[[[5-hydroxy-4-(hydroxymethyl)-6-methyl-3-pyridyl]methyldisulfanyl]methyl]-4-(hydroxymethyl)-2-methyl-pyridin-3-ol
65. Ac-12193
66. As-13595
67. Smr001550535
68. Sbi-0207045.p001
69. Db-050233
70. Ft-0674240
71. P2250
72. C71346
73. D02160
74. Ab00375835_02
75. A802103
76. Q416361
77. Sr-01000872772
78. Sr-01000872772-1
79. W-108702
80. Brd-k82181219-001-01-9
81. Bis(4-hydroxymethyl-5-hydroxy-6-methyl-3-pyridylmethyl)disulfide
82. 5,5'-(dithiodimethylene) Bis[3-hydroxy-4-hydroxymethyl-2-methylpyridine]
83. 5,5'-(dithiodimethylene)bis[3-hydroxy-4-hydroxymethyl-2-methylpyridine]
84. 5,5'-[disulfanediylbis(methylene)]bis[4-(hydroxymethyl)-2-methyl-3-pyridinol]
85. 4-(hydroxymethyl)-5-[[[4-(hydroxymethyl)-6-methyl-5-oxidanyl-pyridin-3-yl]methyldisulfanyl]methyl]-2-methyl-pyridin-3-ol
86. 5-[[[5-hydroxy-4-(hydroxymethyl)-6-methyl-3-pyridinyl]methyldisulfanyl]methyl]-4-(hydroxymethyl)-2-methyl-3-pyridinol
Molecular Weight | 368.5 g/mol |
---|---|
Molecular Formula | C16H20N2O4S2 |
XLogP3 | 1.2 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 7 |
Exact Mass | 368.08644947 g/mol |
Monoisotopic Mass | 368.08644947 g/mol |
Topological Polar Surface Area | 157 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 346 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
N - Nervous system
N06 - Psychoanaleptics
N06B - Psychostimulants, agents used for adhd and nootropics
N06BX - Other psychostimulants and nootropics
N06BX02 - Pyritinol
Market Place
ABOUT THIS PAGE
A Pyritinol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pyritinol, including repackagers and relabelers. The FDA regulates Pyritinol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pyritinol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pyritinol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pyritinol supplier is an individual or a company that provides Pyritinol active pharmaceutical ingredient (API) or Pyritinol finished formulations upon request. The Pyritinol suppliers may include Pyritinol API manufacturers, exporters, distributors and traders.
click here to find a list of Pyritinol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Pyritinol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pyritinol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pyritinol GMP manufacturer or Pyritinol GMP API supplier for your needs.
A Pyritinol CoA (Certificate of Analysis) is a formal document that attests to Pyritinol's compliance with Pyritinol specifications and serves as a tool for batch-level quality control.
Pyritinol CoA mostly includes findings from lab analyses of a specific batch. For each Pyritinol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pyritinol may be tested according to a variety of international standards, such as European Pharmacopoeia (Pyritinol EP), Pyritinol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pyritinol USP).
LOOKING FOR A SUPPLIER?